Philippe Aftimos
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 100
- HER2/EGFR in Cancer Research 45
- Cancer Treatment and Pharmacology 26
-
- Advanced Breast Cancer Therapies 40
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Ahmad Awada (53 shared papers)Martine Piccart (24 shared papers)Christos Sotiriou (7 shared papers)Michail Ignatiadis (9 shared papers)David Venet (3 shared papers)Evandro de Azambuja (14 shared papers)Sylvie Rottey (15 shared papers)Yacine Barèche (1 shared paper)
- Journals
- Journal of Clinical Oncology (34 papers)Annals of Oncology (23 papers)Cancer Research (11 papers)European Journal of Cancer (6 papers)ESMO Open (5 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Philippe Aftimos
133 papers receiving 3.0k citations
Philippe Aftimos's Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 1.9k
- Cancer Research 785
- Radiology, Nuclear Medicine and Imaging 690
- Pulmonary and Respiratory Medicine 809
- Genetics 179
Countries citing papers authored by Philippe Aftimos
This map shows the geographic impact of Philippe Aftimos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Aftimos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Aftimos more than expected).
Fields of papers citing papers by Philippe Aftimos
This network shows the impact of papers produced by Philippe Aftimos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Aftimos. The network helps show where Philippe Aftimos may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Aftimos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study Hit paper breakdown → | 2019 | 400 |
| 2 | 2018 | 254 | |
| 3 | 2018 | 202 | |
| 4 | Delivering precision oncology to patients with cancer Hit paper breakdown → | 2022 | 197 |
| 5 | 2021 | 168 | |
| 6 | 2020 | 94 | |
| 7 | 2021 | 85 | |
| 8 | 2021 | 84 | |
| 9 | 2016 | 71 | |
| 10 | 2019 | 60 | |
| 11 | 2018 | 53 | |
| 12 | 2019 | 50 | |
| 13 | 2017 | 47 | |
| 14 | 2017 | 42 | |
| 15 | 2014 | 40 | |
| 16 | 2021 | 39 | |
| 17 | 2024 | 33 | |
| 18 | 2020 | 33 | |
| 19 | 2015 | 29 | |
| 20 | 2020 | 28 |
About Philippe Aftimos
Philippe Aftimos is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 144 papers that have together received 3.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (45 papers), Advanced Breast Cancer Therapies (40 papers), Cancer Treatment and Pharmacology (26 papers), Breast Cancer Treatment Studies (22 papers), Cancer Genomics and Diagnostics (19 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Lung Cancer Treatments and Mutations (12 papers) and Estrogen and related hormone effects (11 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (785 citations), Radiology, Nuclear Medicine and Imaging (690 citations), Pulmonary and Respiratory Medicine (809 citations) and Genetics (179 citations). Philippe Aftimos has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Ahmad Awada, Martine Piccart, Christos Sotiriou, Michail Ignatiadis, David Venet, Evandro de Azambuja, Sylvie Rottey, Yacine Barèche, Françoise Rothé and Elisabeth G.E. de Vries. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, European Journal of Cancer and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.